• Please log in or register to access this feature.

Psoriatic Arthritis

You have full text access to this OnlineOpen article

Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort

  1. Laura C. Coates1,
  2. Richard Cook2,
  3. Ker-Ai Lee2,
  4. Vinod Chandran3,
  5. Dafna D. Gladman3,*

Article first published online: 26 FEB 2010

DOI: 10.1002/acr.20162

Issue

Arthritis Care & Research

Arthritis Care & Research

Volume 62, Issue 7, pages 970–976, July 2010

Additional Information

How to Cite

Coates, L. C., Cook, R., Lee, K.-A., Chandran, V. and Gladman, D. D. (2010), Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care Res, 62: 970–976. doi: 10.1002/acr.20162

Author Information

  1. 1

    University of Leeds, Chapel Allerton Hospital, Leeds, UK

  2. 2

    University of Waterloo, Waterloo, Ontario, Canada

  3. 3

    University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada

*Toronto Western Research Institute, University Health Network, Toronto Western Hospital, 399 Bathurst Street, 1E-410B, Toronto, Ontario, Canada M5T 2S8

Publication History

  1. Issue published online: 29 JUN 2010
  2. Article first published online: 26 FEB 2010
  3. Manuscript Accepted: 18 FEB 2010
  4. Manuscript Received: 24 AUG 2009

Funded by

  • Arthritis Research UK as an Arthritis Research UK Clinical Research Fellow
  • University of Toronto psoriatic arthritis clinic was supported by the Royal College of Physicians John Glyn Bursary
  • Canadian Institutes of Health Research Clinical Research Initiative Fellowship
  • Krembil Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (80K)

REFERENCES

  • 1
    Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA): an analysis of 220 patients. Q J Med 1987; 62: 127–41.
  • 2
    Gladman DD, Stafford-Brady F, Chang CH, Lewandowski K, Russell ML. Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol 1990; 17: 809–12.
  • 3
    Bond SJ, Farewell VT, Schentag CT, Gladman DD, Bond SJ, Farewell VT, et al. Predictors for radiological damage in psoriatic arthritis: results from a single centre. Ann Rheum Dis 2007; 66: 370–6.
  • 4
    Mease PJ, Gladman DD, Ritchlin CT, Ruderman EM, Steinfeld SD, Choy EH, et al, for the Adalimumab Effectiveness in Psoriatic Arthritis Trial Study Group. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005; 52: 3279–89.
    Direct Link:
  • 5
    Mease PJ, Kivitz AJ, Burch FX, Siegel EL, Cohen SB, Ory P, et al. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 2004; 50: 2264–72.
    Direct Link:
  • 6
    Van der Heijde D, Kavanaugh A, Gladman DD, Antoni C, Krueger GG, Guzzo C, et al, for the IMPACT 2 Study Group. Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: results from the induction and maintenance psoriatic arthritis clinical trial 2. Arthritis Rheum 2007; 56: 2698–707.
    Direct Link:
  • 7
    Cantini F, Niccoli L, Nannini C, Cassara E, Pasquetti P, Olivieri I, et al. Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs. Rheumatology (Oxford) 2008; 47: 872–6.
  • 8
    Gladman DD, Hing EN, Schentag CT, Cook RJ. Remission in psoriatic arthritis. J Rheumatol 2001; 28: 1045–8.
  • 9
    Lindqvist UR, Alenius GM, Husmark T, Theander E, Holmstrom G, Larsson PT. The Swedish early psoriatic arthritis register: 2-year followup. A comparison with early rheumatoid arthritis. J Rheumatol 2008; 35: 668–73.
  • 10
    Kavanaugh A, Fransen J. Defining remission in psoriatic arthritis. Clin Exp Rheumatol 2006; 24 Suppl 43: S83–7.
  • 11
    Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, et al. Minimal disease activity for rheumatoid arthritis: a preliminary definition. J Rheumatol 2005; 32: 2016–24.
  • 12
    Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: a proposed target for treatment. Ann Rheum Dis 2010; 69: 48–53.
  • 13
    Gladman DD, Inman RD, Cook RJ, Maksymowych WP, Braun J, Davis JC, et al. International spondyloarthritis interobserver reliability exercise: the INSPIRE study. II. Assessment of peripheral joints, enthesitis, and dactylitis. J Rheumatol 2007; 34: 1740–5.
  • 14
    Healy PJ, Helliwell PS. Measuring dactylitis in clinical trials: which is the best instrument to use? J Rheumatol 2007; 34: 1302–6.
  • 15
    Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, et al. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum 2009; 61: 1235–42.
    Direct Link:
  • 16
    Gladman DD, Cook RJ, Schentag C, Feletar M, Inman RI, Hitchon C, et al. The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada. J Rheumatol 2004; 31: 1126–31.
  • 17
    Gladman DD, Farewell V, Buskila D, Goodman R, Hamilton L, Langevitz P, et al. Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol 1990; 17: 62–4.
  • 18
    Wakefield RJ, Green MJ, Marzo-Ortega H, Conaghan PG, Gibbon WW, McGonagle D, et al. Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis 2004; 63: 382–5.
  • 19
    Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006; 54: 3761–73.
    Direct Link:
View Full Article (HTML) Get PDF (80K)